Best practices for drafting strong patent claims

Best practices for drafting strong patent claims

Published In the life span of any business, the investment goes way beyond the financial aspects. It’s the years of dedication, contemplating, experimenting, and actively refining your idea of a product or service cut through the market. From the moment an idea...
UK Government decides not to reduce or limit R&D tax credits

UK Government decides not to reduce or limit R&D tax credits

Published The UK Government’s 2024 Budget, while squarely focused on tax increases and revenue measures, suggests a pragmatic recognition by the new Labour administration that sustainable tax receipts are ideally underpinned by economic growth and wealth creation. In...
Calcutta High Court issues IP Division Rules

Calcutta High Court issues IP Division Rules

Published The Calcutta High Court recently adopted the much-awaited Intellectual Property Rights Division Rules, 2023 (Calcutta IPD Rules), making it the third High Court in India, after Delhi and Madras, to implement specialized regulations for IP matters. While the...
AstraZeneca challenges Axelpharm’s cancer drug patent

AstraZeneca challenges Axelpharm’s cancer drug patent

Published AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them against encroachers. Its medicines are exempt from sanctions because they are mainly used for the life-preserving treatment of cancer....
USPTO issues final rule on Director Review of PTAB decisions

USPTO issues final rule on Director Review of PTAB decisions

Published On October 1, 2024, the USPTO published a new final rule, Rules Governing Director Review of Patent Trial and Appeal Board (PTAB) Decisions. 89 Fed. Reg. 79,744 (October 1, 2024). The final rule codifies many aspects of the PTAB’s revised interim Director...
The Patent Lawyer - Logo

Subscribe To Our Newsletter

Would you like to receive our popular weekly news alerts straight to your inbox? Solely patent focused and only sent once a week means you can guarantee there will be something you are interested in reading instead of clogging up your inbox with junk. Sign up now!

You have Successfully Subscribed!